Brühl, Germany

Juergen Mistele

This inventor holds 1 USPTO granted patent. Top assignee: Roche Diagnostics Gmbh. Active years: 2002.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Juergen Mistele: Innovator in Biochemical Reagents

Introduction

Juergen Mistele is a notable inventor based in Brühl, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of reagents used for enzymatic determinations.

Latest Patents

Mistele holds a patent for a "Stabilized reagent and method for determining creatine kinase." This invention involves a stabilized reagent for the photometric enzymatic determination of creatine kinase (CK) in biological sample material. The reagent works by forming ATP from creatine phosphate and ADP, allowing for the detection of the ATP formed. It contains an organic or inorganic sulfur compound, preferably in a submolar amount relative to the added CK activator. Notably, this reagent in liquid form remains stable at 2 to 8°C for up to 12 months without significant loss of function. He has 1 patent to his name.

Career Highlights

Juergen Mistele is associated with Roche Diagnostics GmbH, a leading company in the field of medical diagnostics. His work has contributed to advancements in biochemical testing and diagnostics, enhancing the accuracy and reliability of various tests.

Collaborations

Mistele has collaborated with notable colleagues, including Rolf Nagel and Norbert Schroeder. Their combined expertise has likely fostered innovation and development in their respective fields.

Conclusion

Juergen Mistele's contributions to the field of biochemistry, particularly through his patented reagent for determining creatine kinase, highlight his role as an innovator. His work continues to impact the medical diagnostics industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…